CLSTN2-AS1

Across TCGA pan-cancer cohorts, CLSTN2-AS1 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated CLSTN2-AS1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher CLSTN2-AS1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated CLSTN2-AS1 expression acts as an unfavorable survival marker, although some lineages such as ACC and UCS show a favorable association.

ACC, UCS, and CHOL are the cancer types where CLSTN2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.723	0.288	<.001	85	view →
UCS	DFS	Tertile	II,III,IV	0.599	0.128	<.001	62	view →
CHOL	OS	Tertile	III,IV	0.162	0.915	.004	36	view →
UCEC	DFS	Median	IV	0.736	0.351	.004	24	view →
MESO	DFS	Tertile	All	0.715	0.334	.025	24	view →
LUSC	DFS	Median	All	0.793	0.728	.011	23	view →
KICH	OS	Quartile	II,III,IV	0.732	0.941	.009	22	view →
UVM	OS	Median	All	0.878	0.463	.012	18	view →
LUAD	OS	Tertile	IV	0.262	0.618	.045	18	view →
TGCT	DFS	Quartile	All	0.404	0.783	.003	12	view →
PRAD	OS	Median	All	0.973	1.000	.004	12	view →
PAAD	DFS	Median	III,IV	0.118	0.734	.014	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

CLSTN2-AS1–ACC (DFS)

Open the ACC breakdown →